These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31932992)

  • 1. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.
    Joshi S; Evangelisti A; Liao R; Alexander KM
    Curr Cardiol Rep; 2020 Jan; 22(1):1. PubMed ID: 31932992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.
    Mishra S; Joshi S; Ward JE; Buys EP; Mishra D; Mishra D; Morgado I; Fisch S; Lavatelli F; Merlini G; Dorbala S; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1158-H1166. PubMed ID: 30875258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Grogan M; Dispenzieri A; Gertz MA
    Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
    Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
    Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
    Mishra S; Guan J; Plovie E; Seldin DC; Connors LH; Merlini G; Falk RH; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H95-103. PubMed ID: 23624626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
    Guan J; Mishra S; Shi J; Plovie E; Qiu Y; Cao X; Gianni D; Jiang B; Del Monte F; Connors LH; Seldin DC; Lavatelli F; Rognoni P; Palladini G; Merlini G; Falk RH; Semigran MJ; Dec GW; Macrae CA; Liao R
    Basic Res Cardiol; 2013 Sep; 108(5):378. PubMed ID: 23982491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
    Guan J; Mishra S; Qiu Y; Shi J; Trudeau K; Las G; Liesa M; Shirihai OS; Connors LH; Seldin DC; Falk RH; MacRae CA; Liao R
    EMBO Mol Med; 2014 Nov; 6(11):1493-507. PubMed ID: 25319546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac amyloidosis: an approach to diagnosis and management.
    Halwani O; Delgado DH
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis).
    Hofer JF; Wimmer G
    Z Kardiol; 2003 Jan; 92(1):90-5. PubMed ID: 12545307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
    Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
    Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions.
    Bhogal S; Ladia V; Sitwala P; Cook E; Bajaj K; Ramu V; Lavie CJ; Paul TK
    Curr Probl Cardiol; 2018 Jan; 43(1):10-34. PubMed ID: 29173805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
    Ng B; Connors LH; Davidoff R; Skinner M; Falk RH
    Arch Intern Med; 2005 Jun; 165(12):1425-9. PubMed ID: 15983293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-chain cardiac amyloidosis.
    Mankad AK; Sesay I; Shah KB
    Curr Probl Cancer; 2017; 41(2):144-156. PubMed ID: 28117074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Care of Patients with Cardiac Amyloidosis.
    Itzhaki Ben Zadok O; Kornowski R
    Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report.
    Shin JT; Ward JE; Collins PA; Dai M; Semigran HL; Semigran MJ; Seldin DC
    Amyloid; 2012 Dec; 19(4):191-6. PubMed ID: 23126591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
    Imperlini E; Gnecchi M; Rognoni P; Sabidò E; Ciuffreda MC; Palladini G; Espadas G; Mancuso FM; Bozzola M; Malpasso G; Valentini V; Palladini G; Orrù S; Ferraro G; Milani P; Perlini S; Salvatore F; Merlini G; Lavatelli F
    Sci Rep; 2017 Nov; 7(1):15661. PubMed ID: 29142197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
    Barrett CD; Alexander KM; Zhao H; Haddad F; Cheng P; Liao R; Wheeler MT; Liedtke M; Schrier S; Arai S; Weisshaar D; Witteles RM
    JACC Heart Fail; 2020 Jun; 8(6):461-468. PubMed ID: 32387068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual Case of Cardiac Amyloidosis Preceded by a Twenty-year History of Dilated Cardiomyopathy and Heart Failure.
    Shimada S; Maekura S; Ino H; Matsuura M; Masunaga N; Matsumoto T; Hama J
    Intern Med; 2016; 55(9):1109-15. PubMed ID: 27150863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.